Loading market dashboard
Teladoc Health, Inc.
TDOCHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
TDOC teams with Walmart to offer virtual urgent care, dermatology and nutrition services, expanding affordable telehealth access nationwide.
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced its services are now available through Walmart's Better Care Services platform, expanding access to convenient, affordable care for customers. The collaboration brings Teladoc Health's suite of offerings – including virtual urgent care, dermatology, and nutrition services – to customers seeking both insured and cash-pay options.
It would be quite the feat for this struggling company.
Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector's short history, and bargain hunters are circling the wreckage.
Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.
Hims & Hers and Teladoc Health are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
Teladoc Health Inc (NYSE:TDOC) shares are tumbling during Thursday's pre-market session after the company posted mixed quarterly results and issued guidance that points to continued losses. Here's what investors need to know.
Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teladoc (TDOC) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.19 per share a year ago.
Teladoc Health (NYSE:TDOC) reported mixed first-quarter financial results that have shares falling on Wednesday after market close.
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2025 (“First Quarter 2025”).
HIMS broadens digital-first care with Novo Nordisk GLP-1 access, new cancer detection and Labs tools, along with expansion into Canada and Europe.
Evaluate the expected performance of Teladoc (TDOC) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
When shopping for deals on equity markets, it's important not to catch a falling knife.
The latest trading day saw Teladoc (TDOC) settling at $5.7, representing a -3.72% change from its previous close.
Teladoc (TDOC) closed the most recent trading day at $5.69, moving 2.23% from the previous trading session.
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Teladoc Health is transitioning from a cyclical D2C model to a higher-margin, data-driven B2B platform, supporting a Buy rating at low multiples. TDOC's BetterHelp segment is pivoting to insurance reimbursement, aiming for $75–90M in 2026 insurance revenue, reducing churn and acquisition costs. Integrated Care leverages PulseAI and proprietary datasets to deliver predictive, high-ROI services to employers and health plans, supporting premium pricing and margin expansion.
Teladoc Health, Inc. (NYSE: TDOC - Get Free Report) shares crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $5.13 and traded as low as $5.06. Teladoc Health shares last traded at $5.0950, with a volume of 3,329,660 shares changing hands. Wall Street Analysts
Find out how we performed and what we learned along the way.
TDOC trades at a discount as Teladoc expands AI-driven care, cuts costs, and eyes better profitability, but BetterHelp weakness and rising competition cloud outlook.
Teladoc (TDOC) reached $5.28 at the closing of the latest trading day, reflecting a -3.12% change compared to its last close.
Philadelphia, Pennsylvania--(Newsfile Corp. - April 1, 2026) - What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of Teladoc Health, Inc. (NYSE: TDOC).
Activist investor Pineal Capital Management has urged sweeping changes at Teladoc Health , calling for cost cuts and a potential breakup of the telehealth provider to unlock shareholder value.
DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management: Board of DirectorsTeladoc Health, Inc.2 Manhattanville Road, Suite 203Purchase, NY 10577 31s t March 2026 **See disclaimers at end of letter** Dear Members of the Board, Management and Fellow Stakeholders, Pineal Capital Management (“We”), the Advisor to Pineal Capital Fund 1 (the ‘'Fund''), is a special opportunities investment advisor, seeking deep-value opportunities within secular growth markets, with a specific focus on companies that are under-owned, under-researched and underperforming. Pineal Capital Fund 1 is a shareholder in Teladoc Health (“Teladoc” or the “Company”).
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US.
Teladoc Health (NYSE: TDOC - Get Free Report) and Zicix (OTCMKTS:ZICXD - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings. Risk and Volatility Teladoc Health has a beta
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Teladoc Health (NYSE: TDOC) has staged a notable recovery off its lows, but the stock remains under significant pressure from its longer-term trajectory. Shares are up 1.37% over the past week and have gained 3.83% over the past month, yet they remain down 21.21% year-to-date and nearly 36% over the past year. The stock sits well... Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows?.
In the latest trading session, Teladoc (TDOC) closed at $5.42, marking a -1.09% move from the previous day.
Teladoc (TDOC) closed at $5.42 in the latest trading session, marking a -3.39% move from the prior day.
In the latest trading session, Teladoc (TDOC) closed at $5.47, marking a -1.8% move from the previous day.
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Teladoc Health, Inc. (TDOC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Teladoc Health Inc. (NYSE: TDOC) shares are up on Tuesday.
Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus for each.
